Tweet
Over the past few years working in the medical field, I've realized that many international patients still know very little about CAR-T therapy in China.
I work at DengYueMed, where I help connect international patients with Chinese hospitals and specialists. Over the last two years, I've worked with patients and families from Ethiopia, Malaysia, the Middle East, and other Southeast Asian countries. Before reaching out to us, many of them still viewed Chinese healthcare through the lens of what it was 10 or even 20 years ago. Some were surprised to learn that China has become one of the most active countries in the world for CAR-T research and clinical application.
One thing that has stood out to me is that many patients initially consider the United States or Europe for treatment. However, after doing more research, some discover that China not only has extensive clinical experience with CAR-T therapy but also offers access to a wider range of treatment options for certain indications. For patients with hematologic malignancies, several CAR-T products have already been approved in China, while numerous clinical trials are still actively recruiting.
Another factor that comes up frequently is cost.
CAR-T therapy is expensive no matter where it is performed. However, many international patients find that some CAR-T programs in China, along with the associated hospitalization costs, can be significantly more accessible compared with treatment in the US or parts of Europe. For families paying out of pocket, this can make a meaningful difference.
Of course, every patient's situation is different. CAR-T is not suitable for everyone, and not every patient will benefit from it. That said, based on the cases I've seen, more and more international patients are beginning to consider China as a treatment destination rather than limiting their options to Western countries.
China's progress in oncology over the past several years has been remarkable. From CAR-T therapies to bispecific antibodies, ADCs, and other innovative targeted treatments, an increasing number of international patients are reaching out to explore whether there may be options available in China that could fit their situation.
Sometimes I feel that the information gap is larger than the geographic distance.
Many patients don't lack treatment opportunities—they simply don't know what options exist.
Has anyone here looked into or considered traveling to China for CAR-T therapy or other cancer treatments? I'd be interested to hear your experiences and thoughts on cancer care in China.